PGF and hypertensive disorder: Between 2004 and 2005, Levine et al. identified that high levels of sFlt-1 and reduced PlGF are detectable even up to 5 weeks before the appearance of the classic clinical manifestations of PE, such as hypertension, proteinuria, and glomerular endotheliosis.